BackCity Therapeutics Overview

City Therapeutics Receivables

Latest receivables for CTY: $410M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$413.00M
↓ 21.48% YoYΔ $-113.00M vs prior year quarter

Peer trimmed avg / median

Loading

City Therapeutics Receivables History

Loading

City Therapeutics vs. peers: Receivables Comparison

Loading

City Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

City Therapeutics (CTY) FAQ

City Therapeutics (CTY) currently reports a receivables of $410M as of June 2020. That compares with $530M in the prior-year period — down 21.5% year over year. Use the charts on this page to explore City Therapeutics's receivables history and peer comparisons.

City Therapeutics's receivables decreased from $530M to $410M — a 21.5% year-over-year decrease (period ending June 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

City Therapeutics reported $410M in receivables as of June 2020. That compares with $530M in the prior-year period — down 21.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $410M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for City Therapeutics, and consider following CTY for alerts when major investors trade the stock.

City Therapeutics is classified in the Healthcare sector. On receivables, it currently shows $410M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CTY with unrelated industries.

Questions & Answers